Skip to content
Menu

Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $200

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $95 to $200.

Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $95 to $200.

Read at benzinga.com